Glucocorticoids regulate thrombopoiesis by remodeling the megakaryocyte transcriptome
Journal of Thrombosis and Haemostasis · 2023
DOI: 10.1016/j.jtha.2023.06.012 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Thrombosis and Haemostasis, 2023. Verfasst von Matías Grodzielski und 1 weiteren Autor:innen. Beteiligte Einrichtung: Molecular Endocrinology Group, Signal Transduction Laboratory, National Institute of Environmental Health Sciences, National Institutes of Health, Re…. Hauptthemen laut MEDLINE: Purpura, Thrombocytopenic, Idiopathic, Guanine Deaminase, Thrombocytopenia. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Intramural NIH HHS, National Institutes of Health, National Institute of Environmental Health Sciences.
Abstract (Originalsprache)
BACKGROUND: Glucocorticoids are widely known for their immunomodulatory action. Their synthetic analogs are used to treat several autoimmune diseases, including immune thrombocytopenia. However, their efficacy and mechanisms of action in immune thrombocytopenia are not fully understood. OBJECTIVES: To investigate the mechanism of glucocorticoid actions on platelet production. METHODS: The actions of glucocorticoids on platelet production were studied combining in vivo, ex vivo and in vitro approaches. RESULTS: Dexamethasone reduced bleeding in mice and rapidly increased circulating young platelet counts. In vitro glucocorticoid treatment stimulated proplatelet formation by megakaryocytes and platelet-like particle release. This effect was blocked by glucocorticoid receptor antagonist RU486, indicating a glucocorticoid receptor-dependent mechanism. Genome-wide analysis revealed that dexamethasone regulates the expression of >1000 genes related to numerous cellular functions, including predominant cytoplasm and cytoskeleton reorganization. Dexamethasone and other glucocorticoids induced the expression of Gda (the gene encoding guanine deaminase), which has been reported to have a role in dendrite development. Inhibition of guanine deaminase enzymatic activity blocked dexamethasone stimulation of proplatelet formation, implicating a critical role for this enzyme in glucocorticoid-mediated platelet production. CONCLUSION: Our findings identify glucocorticoids as new regulators of thrombopoiesis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Molecular Endocrinology Group, Signal Transduction Laboratory, National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, North Carolina, USA.
- Molecular Endocrinology Group, Signal Transduction Laboratory, National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, North Carolina, USA. Electronic address: cidlows…
Förderung
- Intramural NIH HHS
- National Institutes of Health
- National Institute of Environmental Health Sciences
Zitieren
APA
Grodzielski, M., & Cidlowski, J. A. (2023). Glucocorticoids regulate thrombopoiesis by remodeling the megakaryocyte transcriptome. Journal of Thrombosis and Haemostasis. https://doi.org/10.1016/j.jtha.2023.06.012
Vancouver
Grodzielski M, Cidlowski JA. Glucocorticoids regulate thrombopoiesis by remodeling the megakaryocyte transcriptome. Journal of Thrombosis and Haemostasis. 2023. doi:10.1016/j.jtha.2023.06.012
BibTeX
@article{Grodzielski2023,
author = {Grodzielski, Matías and Cidlowski, John A},
title = {Glucocorticoids regulate thrombopoiesis by remodeling the megakaryocyte transcriptome},
journal = {Journal of Thrombosis and Haemostasis},
year = {2023},
doi = {10.1016/j.jtha.2023.06.012}
}
EUVIMED